Upregulation of microRNA‑383 inhibits the proliferation, migration and invasion of colon cancer cells

Cui,Ying; Chen,Le‑Gao; Yao,Hai‑Bo; Zhang,Jun; Ding,Ke‑Feng

doi:10.3892/ol.2017.7409

Upregulation of microRNA‑383 inhibits the proliferation, migration and invasion of colon cancer cells

Authors:
- Ying Cui
- Le‑Gao Chen
- Hai‑Bo Yao
- Jun Zhang
- Ke‑Feng Ding
View Affiliations

Affiliations: Department of Surgical Oncology, The Second Affiliated Hospital, Zhejiang University of Medicine, Hangzhou, Zhejiang 310009, P.R. China, Department of Gastrointestinal Surgery, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang 310014, P.R. China, Department of Gastroenterology, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang 310014, P.R. China
Published online on: November 14, 2017 https://doi.org/10.3892/ol.2017.7409
Pages: 1184-1190
Copyright: © Cui et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Increasing evidence demonstrates that microRNAs (miRNAs/miRs), a type of non‑coding small RNA, can regulate tumor cell migration, invasion and metastasis, and may therefore serve a major function in the occurrence and development of tumors. The present study investigated the effect of miR‑383 on the proliferation, migration and invasion of colon cancer HT‑29 and LoVo cell lines. The expression of miR‑383 in colon cancer and adjacent non‑tumor tissues was examined by reverse transcription‑quantitative polymerase chain reaction. MiR‑383 upregulation was stimulated by transfection with a miR‑383 mimic. Cell proliferation was measured with MTT and colony formation assays, and cell migration and invasion potential were examined by Transwell chamber assays. A proliferating‑inducing ligand (APRIL), myeloid cell leukemia‑1 and cyclooxygenase‑2 protein expression was analyzed by western blotting. The expression of miR‑383 was decreased in colon cancer tissues compared with adjacent non‑tumor tissues (P<0.05). Transfection with a miR‑383 mimic suppressed proliferation and inhibited cell migration and invasion in HT‑29 and LoVo colon cancer cell lines. Overexpression of miR‑383 in HT‑29 and LoVo cells resulted in the suppression of APRIL protein expression. In conclusion, miR‑383 was downregulated in colon cancer. The upregulation of miR‑383 inhibited proliferation, migration and invasion of colon cancer cells, potentially through the regulation of target gene APRIL.

View Figures

View References

1	Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
2	Fritzmann J, Morkel M, Besser D, Budczies J, Kosel F, Brembeck FH, Stein U, Fichtner I, Schlag PM and Birchmeier W: A colorectal cancer expression profile that includes transforming growth factor inhibitor BAMBI predicts metastatic potential. Gastroenterology. 137:165–175. 2009. View Article : Google Scholar : PubMed/NCBI
3	Di Leva G, Garofalo M and Croce CM: MicroRNAs in cancer. Annu Rev Pathol. 9:287–314. 2014. View Article : Google Scholar : PubMed/NCBI
4	Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 116:281–297. 2004. View Article : Google Scholar : PubMed/NCBI
5	Heinsbroek SE, Squadrito ML, Schilderink R, Hilbers FW, Verseijden C, Hofmann M, Helmke A, Boon L, Wildenberg ME, Roelofs JJ, et al: MiR-511-3p, embedded in the macrophage mannose receptor gene, contributes to intestinal inflammation. Mucosal Immunol. 9:960–973. 2016. View Article : Google Scholar : PubMed/NCBI
6	Akbari A, Ghahremani MH, Mobini GR, Abastabar M, Akhtari J, Bolhassani M and Heidari M: Down-regulation of miR-135b in colon adenocarcinoma induced by a TGF-β receptor I kinase inhibitor (SD-208). Ran J Basic Med Sci. 18:856–861. 2015.
7	Wang XM, Zhang SF, Cheng ZQ, Peng QZ, Hu JT, Gao LK, Xu J, Jin HT and Liu HY: MicroRNA-383 regulates expression of PRDX3 in human medulloblastomas. Zhonghua Bing Li Xue Za Zhi. 41:547–552. 2012.(In Chinese). PubMed/NCBI
8	Zhao L, Gu H, Chang J, Wu J, Wang D, Chen S, Yang X and Qian B: MicroRNA-383 regulates the apoptosis of tumor cells through targeting Gadd45g. PLoS One. 9:e1104722014. View Article : Google Scholar : PubMed/NCBI
9	Chen L, Guan H, Gu C, Cao Y, Shao J and Wang F: miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL. Tumour Boil. 37:2497–2507. 2016. View Article : Google Scholar
10	Hahne M, Kataoka T, Schröter M, Hofmann K, Irmler M, Bodmer JL, Schneider P, Bornand T, Holler N, French LE, et al: APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth, stimulates tumor cell growth. J Exp Med. 188:1185–1190. 1998. View Article : Google Scholar : PubMed/NCBI
11	Mhawech-Fauceglia P, Kaya G, Sauter G, McKee T, Donze O, Schwaller J and Huard B: The source of APRIL up-regulation in human solid tumor lesions. J Leukoc Biol. 80:697–704. 2006. View Article : Google Scholar : PubMed/NCBI
12	Mhawech-Fauceglia P, Allal A, Odunsi K, Andrews C, Herrmann FR and Huard B: Role of the tumour necrosis family ligand APRIL in solid tumour development: Retrospective studies in bladder, ovarian and head and neck carcinomas. Eur J Cancer. 44:2097–2100. 2008. View Article : Google Scholar : PubMed/NCBI
13	Lascano V, Zabalegui LF, Cameron K, Guadagnoli M, Jansen M, Burggraaf M, Versloot M, Rodermond H, van der Loos C, Carvalho-Pinto CE, et al: The TNF family member APRIL promotes colorectal tumorigenesis. Cell Death Differ. 19:1826–1835. 2012. View Article : Google Scholar : PubMed/NCBI
14	Wang GH, Lu MH, Wang JC, Wang F, Ding WF, Wang YG, Ju SQ and Wang HM: Abnormal expression of APRIL in colorectal cancer cells promotes tumor growth and metastasis. Zhonghua Zhong Liu Za Zhi. 35:249–255. 2013.(In Chinese). PubMed/NCBI
15	Ding W, Wang J, Sun B, Ju S, Yuan H, Wang X, Wang Y and Wang H: APRIL knockdown suppress migration and invasion of human colon caner cells. Clin Biochem. 42:1694–1698. 2009. View Article : Google Scholar : PubMed/NCBI
16	Zhan J, Liu JP, Zhu ZH, Yao HR and Chen CY: Relationship between COX-2 expression and clinicopathological features of colorectal cancers. Chin Med J. 117:1151–1154. 2004.PubMed/NCBI
17	Basu GD, Liang WS, Stephan DA, Wegener LT, Conley CR, Pockaj BA and Mukherjee P: A novel role for cyclooxygenase-2 in regulating vascular channel formation by human breast cancer cells. Breast Cancer Res. 8:R692006. View Article : Google Scholar : PubMed/NCBI
18	Tsujli M, Kawano S, Tsuji S, Swaoka H, Hori M and DuBois RN: Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell. 93:705–716. 1998. View Article : Google Scholar : PubMed/NCBI
19	Akgul C: Mcl-1is a potential therapeutic target in multiple types of cancer. Cell Mol Life Sci. 66:1326–1336. 2008. View Article : Google Scholar
20	Ma XT, Yu LW, Wang S, Du RY and Cui ZR: Molecular mechanism of Stat5b signaling pathway in regulating the expression of bcl-2 family members and promoting survival of human colon cancer cells. Zhonghua Shi Yan Wai Ke Za Zhi. 22:1157–1169. 2005.(In Chinese).
21	Yoon JH, Werneburg NW, Higuchi H, Canbay AE, Kaufmann SH, Akgul C, Edwards SW and Gores GJ: Bile acids inhibit Mcl-1 protein turnover via an epidermal growth factor receptor/Raf-1-dependent mechanism. Cancer Res. 62:6500–6505. 2002.PubMed/NCBI
22	Fan G, Jiang X, Wu X, Fordjour PA, Miao L, Zhang H, Zhu Y and Gao X: Anti-Inflammatory Activity of Tanshinone IIA in LPS-Stimulated RAW264.7 Macrophages via miRNAs and TLR4-NF-κB pathway. Inflammation. 39:375–384. 2016. View Article : Google Scholar : PubMed/NCBI
23	Liao XH, Zheng L, He HP, Zheng DL, Wei ZQ, Wang N, Dong J, Ma WJ and Zhang TC: STAT3 regulated ATR via microRNA-383 to control DNA damage to affect apoptosis in A431 cells. Cell Signal. 27:2285–2295. 2015. View Article : Google Scholar : PubMed/NCBI
24	Sobin LH and Fleming ID: TNM classification of malignant tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer. 80:1803–1804. 1997. View Article : Google Scholar : PubMed/NCBI
25	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
26	Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, et al: MicroRNA expression profiles classify human cancer. Nature. 435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
27	Orellana EA and Kasinski AL: MicroRNAs in cancer: A historical perspective on the path from discovery to therapy. Cancers (Basel). 7:1388–1405. 2015. View Article : Google Scholar : PubMed/NCBI
28	Li C, Wang Y, Lu S, Zhang Z, Meng H, Liang L, Zhang Y and Song B: MiR-34a inhibits colon cancer proliferation and metastasis by inhibiting platelet-derived growth factor receptor α. Mol Med Rep. 12:7072–7078. 2015. View Article : Google Scholar : PubMed/NCBI
29	Liang Y, Zhao Q, Fan L, Zhang Z, Tan B, Liu Y and Li Y: Down-regulation of microRNA-381 promotes cell proliferation and invasion in colon cancer through up-regulation of LRH-1. Biomed Pharmacother. 75:137–141. 2015. View Article : Google Scholar : PubMed/NCBI
30	Roosnek E, Burjanadze M, Dietrich PY, Matthes T, Passweg J and Huard B: Tumors that look for their springtime in APRIL. Crit Rev Oncol Hematol. 72:91–97. 2009. View Article : Google Scholar : PubMed/NCBI
31	Wang G, Wang F, Ding W, Wang X, Xu J, Li H and Wang H: APRIL mediates migration and invasion of colorectal cancer cell via regulation of matrix metalloproteinases. Chin J Microbiol Immunol. 32:128–133. 2012.(In Chinese).